Back

Regional variation in heart failure treatment: an analysis of the VICTOR trial background therapy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in ventricular arrhythmias and sudden cardiac death (2) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Clara Ines Saldarriaga

Cardio Clinical VID, Medellin (Colombia)

5 More presentations in this session

Presentation thumbnail
Effect of different phenotypes of hypertrophic cardiomyopathy on clinical outcomes
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Predicting early atrial fibrillation recurrence post-electrical cardioversion: a critical look at bilateral atrial function
Doctor M. Feola (Mondovi, IT)
Abstract Slides Video
Presentation thumbnail
Carbon dioxide insufflation technique for epicardial access ablation of refractory arrhythmias single tertiary centre experience
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Non-infected lead extractions - single-centre experience
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Aromatase index and prognostic marker for arrhythmia and death in ACS - comparison by gender
Doctor N. Semerdzieva (Sofia, BG)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in ventricular arrhythmias and sudden cardiac death (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Effect of Vericiguat on Mortality in Ambulatory Patients with Heart Failure and Reduced Ejection Fraction: VICTOR Trial Prespecified Analysis
thumbnail
Congress Presentation
What do we know so far?
thumbnail
Congress Presentation
Initial experience with vericiguat treatment in real life. VERITA registry versus the VICTORIA study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources